Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 825

Specific changes in our DNA that increase the risk of developing epilepsy have been discovered, in the largest genetic study of its kind for epilepsy coordinated by the International League Against Epilepsy, which includes scientists from the University of Melbourne and WEHI (Walter and Eliza Hall Institute of Medical Research).

Published today in Nature Genetics, this research advances our understanding of why epilepsy develops and could inform the development of new epilepsy treatments. The research was produced by the International League Against Epilepsy (ILAE) Consortium on Complex Epilepsies.

Epilepsy is a common brain disorder estimated to effect more than 50 million people worldwide, where nerve cell activity in the brain is disturbed, causing seizures. It has a genetic component that sometimes runs in families. In this study, researchers compared the DNA from almost 30,000 people with epilepsy to the DNA of 52,500 people without epilepsy from around the world. The differences between the two groups highlighted areas of DNA that may be involved in the development of epilepsy.

Read more | >

In April of this year, Spanish athlete Beatriz Flamini emerged into the light after a 500-day stay in a cave. Her descent underground is probably the longest undertaken by a long stretch. Flamini says she lost all sense of time on the 65th day. But can she really be sure it was the 65th day? By way of comparison, in 1962 France’s Michel Siffre surfaced from the Scarasson chasm in Italy after spending what he thought was 33 days there. In fact, he spent 58 days underground.

How can isolated human beings keep regular track of time, even when they’re disconnected from their surrounding environment? Quite simply, because biological rhythms are at the heart of life, regulating it all the way from the up to that of the entire body. These include not only our sleep/, but also body temperature, hormones, metabolism and the cardiovascular system, to name but a few.

And these rhythms have many repercussions, not least in terms of public health. Indeed, a number of diseases are episodic—for example, asthma is more severe at night, while cardiovascular accidents are more frequent in the morning. Another example is shift work, which disconnects people from their environment. It may be associated with an increased risk of cancers in workers, prompting the WHO to label it as a probable carcinogen.

Read more | >

Dr. Kimathi is a medical oncologist in a community setting where she sees patients with a variety of cancer diagnoses. Recently, she had several patients with toxicities to different treatments, including tamoxifen, cisplatin, and methotrexate. Concerned, she wondered if there was a common factor these patients shared to have experienced these toxicities. On review, she found that these patients had different cancer diagnoses and did not share any known comorbidities or risk factors.

Why do some cancer patients experience toxicities from certain treatments and others don’t? Drug metabolism is highly variable among patients, and even within the same patient, depending on age and disease state. Both the toxicity and efficacy of cancer chemotherapy can be affected by many different factors, including other medications, foods, dietary supplements, environmental conditions, and genetic variants in drug-metabolizing genes and drug transporters.

Read more | >

Throughout Gray’s life before she got the treatment, the deformed, sickle-shaped red blood cells caused by the genetic disorder would regularly incapacitate her with intense, unpredictable attacks of pain. Those crises would send Gray rushing to the hospital for pain medication and blood transfusions. She could barely get out of bed many days; when she became a mom, she struggled to care for her four children and couldn’t finish school or keep a job.

But then she received the treatment on July 2, 2019. Doctors removed some of her bone marrow cells, genetically modified them with CRISPR and infused billions of the modified cells back into her body. The genetic modification was designed to make the cells produce fetal hemoglobin, in the hopes the cells would compensate for the defective hemoglobin that causes the disease.

A Mississippi woman’s life has been transformed by a treatment for sickle cell disease with the gene-editing technique CRISPR. All her symptoms from a disease once thought incurable have disappeared.

Read more | >

It’s the beginning of the flu season and hospitals in the city have reported an increase in the number of people coming in with fever, severe body pain, and fatigue. Infectious diseases expert Dr V Ramasubramanian in an interview to Pushpa Narayan explains why people should take the flu shot.

Will the flu vaccine prevent the flu?

The flu vaccine prevents the infection in up to 70% of cases, and reduces the chances of severe disease. The infection can stimulate inflammation of different parts of the body including blood vessels. This leads to a series of complications in the body including heart attacks and strokes.

Read more | >

Interfacing modern electronics-based technology with biology is notoriously difficult. One major stumbling block is that the way they are powered is very different. While most of our gadgets run on electrons, nature relies on the energy released when the chemical bonds of ATP are broken. Finding ways to convert between these two very different currencies of energy could be useful for a host of biotechnologies.

Genetically engineered microbes are already being used to produce various high-value chemicals and therapeutically useful proteins, and there are hopes they could soon help generate greener jet fuel, break down plastic waste, and even grow new foods in giant bioreactors. But at the minute, these processes are powered through an inefficient process of growing biomass, converting it to sugar, and feeding it to the microbes.

Now, researchers at the Max Planck Institute for Terrestrial Microbiology in Germany have devised a much more direct way to power biological processes. They have created an artificial metabolic pathway that can directly convert electricity into ATP using a cocktail of enzymes. And crucially, the process works in vitro and doesn’t rely on the native machinery of cells.

Read more | >

AI helps implants work better, preventing diseases before they happen despite immune system challenges.

Imagine your body had an implant that could continuously monitor the occurrence of diseases and infections and immediately release medications to prevent them. Wouldn’t that be ideal, especially for patients who suffer from conditions like heart failure, diabetes, and asthma?

You’d be surprised to know that such implants do exist, but the human body doesn’t allow them to work. Our immune system recognizes such devices as foreign substances.

Read more | >

Michael Levin talk for the Mind, Technology, and Society (MTS) talk series at UC Merced on January 23, 2023. Abstract: Each of us makes the remarkable journey from the physics and chemistry of a quiescentunfertilized egg to that of a complex human being. How can we understand the continuousprocesses that scale up minds from the tiny physiological competencies of single cells to the large-scale metacognitive capacities of large brains? Here, I will describe a framework known as TAME-Technological Approach to Mind Everywhere — which enables identifying, understanding, andrelating to unconventional cognitive agents. I will use the example of the collective intelligence ofcells during morphogenesis to illustrate how we can begin to widen the lessons of multiscale neuroscience well beyond neurons. This will be essential as we head into a future that will bepopulated by a wide range of evolved, designed, and hybrid beings with novel bodies and novelminds. I will conclude with a case study of our new synthetic biorobot (Xenobots) and a discussionof the implications of these ideas for evolution, biomedicine, and ethics.

Read more | >

Consciousness is usually ascribed to a specific set of mechanisms and functional capabilities of the complex brain. Importantly, those mechanisms (ion channels, electrical networks, neurotransmitter machinery) long pre-date the evolutionary innovation of nervous systems. Moreover, the algorithms and competencies such as memory, decision-making, and information integration likewise have an ancient evolutionary origin: before they controlled moving the body through 3D space, electrical networks moved body configurations through anatomical morphospace. In this talk, I will describe how we view the morphogenesis during embryonic development and regeneration as the behavior of a collective intelligence, which has many problem-solving capacities. I will describe the tools we have developed, paralleling neuroscientists’ attempts to read and write mental content by control of electrophysiology, to decode and re-write the pattern memories of the body. This has significant implications not only for biomedicine and evolutionary biology, but also for questions about consciousness and the scaling of coherent Selves from agential materials. I will conclude with some conjectures about what this new field offers the science of consciousness, in the form of new embodied living creatures that are outside the natural evolutionary stream of Earth, and the quest for theories of consciousness.-https://www.drmichaellevin.org/ Participate in our online research survey-Survey on Diverse intelligence-https://tufts.qualtrics.com/jfe/form/SV_eE51vKE34q3hexo (takes 9 minutes). Thank you.

Edited by Emilio Manzotti.
https://github.com/emilim/

Read more | >